Citius Pharmaceuticals In... (CTXR)
NASDAQ: CTXR
· Real-Time Price · USD
1.39
0.01 (0.72%)
At close: Aug 19, 2025, 9:41 AM
Citius Pharmaceuticals Income Statement
Financials in USD. Fiscal
year is
October - September.
| Fiscal Year | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 |
Revenue | n/a | n/a | n/a | 155.93K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 41.37K | 56.01K | 54.84K | 155.93K | 52.85K | 52.07K | 51.01K | 49.97K | 49.02K | n/a | 47.19K | 46.25K | 45.35K | 44.47K | 43.61K | 42.77K | 41.68K | 40.59K | n/a |
Gross Profit | -41.37K | -56.01K | -54.84K | n/a | -52.85K | -52.07K | -51.01K | -49.97K | -49.02K | n/a | -47.19K | -46.25K | -45.35K | -44.47K | -43.61K | -42.77K | -41.68K | -40.59K | n/a |
Operating Income | -8.79M | -11.26M | -10.04M | -11.05M | -10.63M | -10.97M | -9.34M | -10.12M | -8.67M | -10.69M | -7.25M | -7.55M | -8.92M | -7.59M | -9.26M | -5.2M | -5.98M | -4.19M | -8.16M |
Interest Income | 20.64K | 13.41K | 22.61K | 117.31K | 204.84K | 182.21K | 253.64K | 324.81K | 336.78K | 303.27K | 214.55K | 134.83K | 53.02K | 29.57K | 33.98K | 75.6K | 103.41K | 69.33K | 13.48K |
Pretax Income | -8.94M | -11.25M | -10.02M | -10.93M | -10.43M | -8.4M | -9.09M | -9.8M | -8.34M | -10.38M | -3.45M | -7.41M | -8.86M | -7.56M | -9.23M | -4.96M | -5.82M | -4.12M | -8.15M |
Net Income | -8.79M | -11.51M | -9.77M | -10.79M | -10.57M | -8.54M | -9.23M | -9.94M | -8.48M | -10.53M | -3.59M | -7.99M | -8.81M | -7.53M | -9.23M | -4.96M | -5.82M | -4.12M | -8.15M |
Selling & General & Admin | 7.13M | 4.79M | 5.39M | 8.14M | 7.87M | 7.36M | 6.72M | 7.24M | 4.91M | 5.96M | 3.8M | 3.69M | 4.03M | 4.14M | 3.8M | 2.91M | 3.78M | 2.64M | 1.97M |
Research & Development | 1.62M | 3.77M | 2.13M | 2.91M | 2.76M | 3.61M | 2.62M | 2.88M | 3.76M | 4.73M | 3.45M | 3.86M | 4.89M | 3.45M | 5.46M | 2.29M | 2.2M | 1.55M | 6.19M |
Other Expenses | n/a | 2.7M | 2.52M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 59.92K | n/a | n/a |
Operating Expenses | 8.75M | 11.26M | 10.04M | 11.05M | 10.63M | 10.92M | 9.34M | 10.12M | 8.67M | 10.69M | 7.25M | 7.55M | 8.92M | 7.59M | 9.26M | 5.2M | 5.98M | 4.19M | 8.16M |
Interest Expense | 172.26K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2.93K | 3.94K | 3.97K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 8.79M | 11.26M | 10.04M | 11.05M | 10.63M | 10.97M | 9.34M | 10.12M | 8.67M | 10.69M | 7.25M | 7.55M | 8.92M | 7.59M | 9.26M | 5.2M | 5.98M | 4.19M | 8.16M |
Income Tax Expense | 264.24K | 264.24K | 264.24K | 144K | 144K | 144K | 144K | 144K | 144K | 144K | 144K | 576K | -53.02K | -29.57K | 33.98K | n/a | n/a | n/a | 13.48K |
Shares Outstanding (Basic) | 11.01M | 11.59M | 11.59M | 11.59M | 11.59M | 10.6M | 10.6M | 10.59M | 10.25M | 9.75M | 9.75M | 9.74M | 9.74M | 9.74M | 9.73M | 9.73M | 9.14M | 6.4M | 3.71M |
Shares Outstanding (Diluted) | 11.01M | 11.59M | 11.59M | 11.59M | 11.59M | 10.6M | 10.6M | 10.59M | 10.25M | 9.75M | 9.75M | 9.74M | 9.74M | 9.74M | 9.73M | 9.76M | 9.14M | 6.4M | 3.71M |
EPS (Basic) | -0.8 | -1.27 | -1.3 | -0.06 | -0.06 | -0.05 | -0.06 | -0.06 | -0.06 | -0.07 | -0.02 | -0.05 | -0.06 | -0.05 | -0.06 | -0.03 | -0.04 | -0.04 | -0.15 |
EPS (Diluted) | -0.8 | -1.27 | -1.3 | -0.06 | -0.06 | -0.05 | -0.06 | -0.06 | -0.06 | -0.07 | -0.02 | -0.05 | -0.06 | -0.05 | -0.06 | -0.03 | -0.04 | -0.04 | -0.15 |
EBITDA | -8.73M | -11.19M | -9.98M | -11M | -10.58M | -10.97M | -9.34M | -10.12M | -8.67M | -10.64M | -7.25M | -7.37M | -8.82M | -7.52M | -9.18M | -4.92M | -5.78M | -4.08M | -8.1M |
EBIT | -8.77M | -11.25M | -10.04M | -11.05M | -10.63M | -10.97M | -9.34M | -10.12M | -8.67M | -10.69M | -7.25M | -7.41M | -8.92M | -7.59M | -9.26M | -4.96M | -5.82M | -4.12M | -8.14M |
Depreciation & Amortization | 41.37K | 56.01K | 54.84K | 53.69K | 52.85K | 52.07K | 51.01K | 49.97K | 49.02K | 48.14K | 47.19K | 46.25K | 45.35K | 44.47K | 43.61K | 42.77K | 41.68K | 40.59K | 39.82K |